The algorithm based on the analysis of ERG, PCA3 and SPDEF showed its advantages in discriminating the high-grade cancer (≥GS7) from low-grade malignancy (GS6) and benign disease than tPSA in CaP screening [23]. The gene discussed is PCA3; the disease is cancer.